1 / 85

Molecular Haematology I Globin Disorders

Molecular Haematology I Globin Disorders. Dr Edmond S K Ma Division of Haematology Department of Pathology The University of Hong Kong. Thalassaemia. First described by Thomas B. Cooley in 1925

ebony
Download Presentation

Molecular Haematology I Globin Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Molecular Haematology IGlobin Disorders Dr Edmond S K Ma Division of Haematology Department of Pathology The University of Hong Kong

  2. Thalassaemia • First described by Thomas B. Cooley in 1925 • The term thalassaemia was first coined in 1932 based on the Greek word qalassa (thalassa) meaning the sea

  3. Prevalence of thalassaemia in Hong Kong Chinese a-thalassaemia 5% b-thalassaemia 3.1%

  4. Prevalence of thalassaemia in Hong Kong Chinese a-thalassaemia (--SEA) a-thalassaemia deletion 90% b-thalassaemia codons 41-42 (-CTTT) b0 45% IVSII-654 (CT) b0 20% nt-28 (AG) b+ 16% codon 17 (AT) b0 8%

  5. Carrier detection • Antenatal screening • Obstetrical Units of the Hospital Authority • Maternal and Child Health Centres • Private sector • Pre-marital and pre-pregnancy testing • Family Planning Association • Community based thalassaemia screening • Children’s Thalassaemia Foundation

  6. Detection of thalassaemia • Red cell indices (MCV, MCH) • Determine iron status • HPLC analysis • Hb and globin chain electrophoresis • Detection of HbH inclusion bodies

  7. Laboratory diagnosis of thalassaemia by HPLC

  8. Haemoglobin electrophoresis

  9. Detection of HbH inclusion bodies

  10. New approaches in diagnosis of SEA deletion:gap-PCR for SEA deletion

  11. New approaches in diagnosis of SEA deletion: detection of z-globin chains in adults

  12. Deletional (common) --SEA -a3.7 -a4.2 Non-deletional (rare) Hb CS Hb QS codon 30 deletion Hb Q-Thailand Hb Westmead a2 codon 31 a2 codon 59 Others a-globin gene mutations

  13. Prevalence of thalassaemia in Hong Kong Chinese (MCV < 80 fL) a-thalassaemia (--SEA) a-thalassaemia deletion 90%

  14. Single a-globin gene deletion and triplicated a-globin gene • Prevalence • 6% for –a3.7 and –a4.2 • Hb 13.6 ± 0.12 g/dL (11.8 – 15.6) • MCV 83.0 ± 0.33 fL (77.9 – 88.1) • MCH 27.2 ± 0.16 pg (24.1 – 29.7) • 1.5% for aaaanti-3.7 and aaaanti-4.2 • Hb 13.5 g/dL, MCV 85.5 fL, MCH 28.7 pg

  15. Single a-globin gene deletion (-a) and triplicated a-globin gene (aaa) configuration

  16. Molecular diagnosis of a-thalassaemiaClark & Thein, Clin Lab Haematol 26: 159-76; 2004 • Deletions • Gap PCR • Southern blotting • Non-deletional mutation: on specifically amplified a2 or a1 genes • Restriction digest • ARMS-PCR • ASO • Direct sequence analysis

  17. Multiplex PCR for 3 commonest a-thalassaemia deletion LIS1 control 3.7 kb deletion a-2 gene 4.2 kb deletion SEA deletion

  18. Multiplex PCR for 3 commonest a-thalassaemia deletion water αα/--SEA ladder -α3.7/--SEA -α4.2/--SEA αα/αα blank LIS internal control (2350 bp) -α3.7 (2022/2029 bp) α2 (1800 bp) -α4.2 (1628 bp) --SEA (1349 bp)

  19. Larger fragment Gel Smaller fragment Key restriction enzyme sites probe region Restriction fragment length polymorphism (RFLP) The principle of RFLP as shown is used to diagnose the different types of -globin genotypes relevant to -thalassaemia.

  20. 16kb 14.5kb 12.6 kb 10.5 kb 7.0 kb

  21. Multiplex ARMS for the 3 commonest non-deletional a2-globin gene mutations Internal control (930 bp) cd30(ΔGAG) (772 bp) HbQS (234 bp) HbCS (184 bp)

  22. Reverse dot blot Chan V et al, BJH 104: 513-5, 1999

  23. Multiplex mini-sequencing screen Wang W et al, Clin Chem 49: 800 – 803, 2003

  24. Molecular screening of non-deletional a-globin gene mutations by denaturing HPLC Guida V et al, Clin Chem 50: 1242 – 1245, 2004

  25. Thalassaemia array Chan K et al, BJH 124: 232 – 239, 2004

  26. Thalassaemia array

  27. b-thalassaemia phenotypes b-thalassaemia trait • Aymptomatic • Hypochromic microcytic red cells • High HbA2 • Variable  HbF • Genotype: simple heterozygotes for b-thalassaemia alleles

  28. b-thalassaemia phenotypes b-thalassaemia major • Onset < 1 year • Transfusion dependent • Many complications • Markedly HcMc RBC • Nucleated reds • Majority HbF • Genotypes: homozygous or compound heterozygous for b-thalassaemia alleles

  29. b-thalassaemia syndromes

  30. Defining disease severity • Age at diagnosis • Steady state or lowest haemoglobin level • Age at first transfusion • Frequency of transfusion • Splenomegaly or age at splenectomy • Height and weight in percentile

  31. Why study genotype phenotype relationship? • Genetic counselling • Management decisions

  32. Genetic factors affecting disease severity • Nature and severity of b-globin mutation • Co-inheritance of a-thalassaemia or triplicated a-globin genes • Genetic determinant(s) for enhanced g-globin chain production

  33. Mutation detection by dot blot hybridization

  34. Detection of five -thalassaemia mutations by ARMS 1 2 3 4 5 6 7 8 Internal control -28 17 43 71-72 654 Internal control Panel 1: 1-6 1: -28 Heterozygote 2: -28/71-72 Compound Heterozygote 3: Codon 17 Heterozygote 4: Codon 43 Heterozygote 5: 100 bp DNA Ladder 6: Reagent Blank Control Panel 2: 7-8 7: IVS 2-654 Heterozygote 8: Reagent BlankControl

  35. Southern blot hybridization with a-probe

  36. PCR-based mutation detection a-multiplex PCR db-thalassaemia PCR

  37. The spectrum of b-thalassaemia alleles in Chinese

  38. Genotype phenotype correlation in b0/b0 thalassaemia

  39. Genotype phenotype correlation in b0/b+ thalassaemia

  40. Homozygous b0/b0 and compound heterozygous b0/b+ thalassaemia

  41. Clinical phenotype of b+/b+ thalassaemia

  42. Clinical phenotype of HbE / b-thalassemia

  43. Molecular pathology of b-thalassaemia

More Related